Recursion Pharmaceuticals, Inc 10-K for FY2024
Recursion Pharmaceuticals, Inc. (RXRX)
10-K
2025-02-28
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Recursion Pharmaceuticals, Inc filed this 10-K on February 28, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $58.84M
- up 32.0% from $44.58M a year earlier
- Net loss
- $463.66M
- compared with a net loss of $328.07M a year earlier
- Diluted EPS
- -$1.69
- compared with -$1.58 a year earlier